521. A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease

por Dow, Geoffrey
Publicado 2023

Effect of sample size and P-value filtering techniques on the detection of transcriptional changes induced in rat neuroblastoma (NG108) cells by mefloquine

por Dow, Geoffrey S
Publicado 2003

The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg)

por Dow, Geoffrey, Smith, Bryan
Publicado 2017

Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki

por Dow, Geoffrey S, Magill, Alan J, Ohrt, Colin
Publicado 2008

Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines

por Berman, Jonathan, Brown, Tracey, Dow, Geoffrey, Toovey, Stephen
Publicado 2018

The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro

por Dow, Geoffrey S, Hudson, Thomas H, Vahey, Maryanne, Koenig, Michael L
Publicado 2003

A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic ar...

por Dow, Geoffrey S, McCarthy, William F, Reid, Mark, Smith, Bryan, Tang, Douglas, Shanks, G Dennis
Publicado 2014

Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries

por Dow, Geoffrey S., Liu, Jun, Lin, Gina, Hetzell, Brian, Thieling, Sarah, McCarthy, William F., Tang, Douglas, Smith, Bryan
Publicado 2015

Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)

por Dow, Geoffrey S, Gettayacamin, Montip, Hansukjariya, Pranee, Imerbsin, Rawiwan, Komcharoen, Srawuth, Sattabongkot, Jetsumon, Kyle, Dennis, Milhous, Wilbur, Cozens, Simon, Kenworthy, David, Miller, Anne, Veazey, Jim, Ohrt, Colin
Publicado 2011

Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols

por Milner, Erin, McCalmont, William, Bhonsle, Jayendra, Caridha, Diana, Cobar, Jose, Gardner, Sean, Gerena, Lucia, Goodine, Duane, Lanteri, Charlotte, Melendez, Victor, Roncal, Norma, Sousa, Jason, Wipf, Peter, Dow, Geoffrey Stuart
Publicado 2010

Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model

por Obaldía III, Nicanor, Dow, Geoffrey S., Gerena, Lucia, Kyle, Dennis, Otero, William, Mantel, Pierre-Yves, Baro, Nicholas, Daniels, Rachel, Mukherjee, Angana, Childs, Lauren M., Buckee, Caroline, Duraisingh, Manoj T., Volkman, Sarah K., Wirth, Dyann F., Marti, Matthias
Publicado 2016

Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice

por Dow, Geoffrey S, Milner, Erin, Bathurst, Ian, Bhonsle, Jayendra, Caridha, Diana, Gardner, Sean, Gerena, Lucia, Kozar, Michael, Lanteri, Charlotte, Mannila, Anne, McCalmont, William, Moon, Jay, Read, Kevin D, Norval, Suzanne, Roncal, Norma, Shackleford, David M, Sousa, Jason, Steuten, Jessica, White, Karen L, Zeng, Qiang, Charman, Susan A
Publicado 2011